These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Barresi V, Cerasoli S, Vitarelli E, Tuccari G. Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108 [Abstract] [Full Text] [Related]
5. Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis. Li C, Gardy R, Seon BK, Duff SE, Abdalla S, Renehan A, O'Dwyer ST, Haboubi N, Kumar S. Br J Cancer; 2003 May 06; 88(9):1424-31. PubMed ID: 12778073 [Abstract] [Full Text] [Related]
6. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF. Yao Y, Pan Y, Chen J, Sun X, Qiu Y, Ding Y. Ann Clin Lab Sci; 2007 May 06; 37(1):39-48. PubMed ID: 17311868 [Abstract] [Full Text] [Related]
7. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas. Netto GC, Bleil CB, Hilbig A, Coutinho LM. Neuropathology; 2008 Feb 06; 28(1):17-23. PubMed ID: 18181830 [Abstract] [Full Text] [Related]
9. Prognostic relevance of CD105-assessed microvessel density in laryngeal carcinoma. Zvrko E, Mikic A, Vuckovic L, Djukic V, Knezevic M. Otolaryngol Head Neck Surg; 2009 Oct 06; 141(4):478-83. PubMed ID: 19786216 [Abstract] [Full Text] [Related]
11. Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients. Pruneri G, Ponzoni M, Ferreri AJ, Decarli N, Tresoldi M, Raggi F, Baldessari C, Freschi M, Baldini L, Goldaniga M, Neri A, Carboni N, Bertolini F, Viale G. Br J Haematol; 2002 Sep 06; 118(3):817-20. PubMed ID: 12181051 [Abstract] [Full Text] [Related]
12. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody. Yao Y, Kubota T, Takeuchi H, Sato K. Neuropathology; 2005 Sep 06; 25(3):201-6. PubMed ID: 16193836 [Abstract] [Full Text] [Related]
17. [Tumor microvascular density detected by anti-CD105 and anti-CD34 in hepatocellular carcinoma patients and its predictive value of tumor recurrence after liver transplantation]. Wang Y, Zhang XH, Guo P, Yan LN, He D. Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep 06; 41(5):818-21. PubMed ID: 21302449 [Abstract] [Full Text] [Related]
18. Microvessel density in head and neck squamous cell carcinoma. Szafarowski T, Sierdzinski J, Szczepanski MJ, Whiteside TL, Ludwig N, Krzeski A. Eur Arch Otorhinolaryngol; 2018 Jul 06; 275(7):1845-1851. PubMed ID: 29748768 [Abstract] [Full Text] [Related]
19. Correlation between selected angiogenic markers and prognosis in pediatric adrenocortical tumors: Angiogenic markers and prognosis in pediatric ACTs. Dias AI, Fachin CG, Avó LR, Frazão CV, Caran EM, Schettini ST, Alves MT, Ribeiro RC, Abib Sde C. J Pediatr Surg; 2015 Aug 06; 50(8):1323-8. PubMed ID: 25783314 [Abstract] [Full Text] [Related]
20. Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy. Miyata Y, Mitsunari K, Asai A, Takehara K, Mochizuki Y, Sakai H. Prostate; 2015 Jan 06; 75(1):84-91. PubMed ID: 25307287 [Abstract] [Full Text] [Related] Page: [Next] [New Search]